Schedule 13G filing

Johnson & Johnson Innovation - JJDC, Inc. disclosed a 5.3% stake in TRex Bio, Inc. (TRXB)

Schedule 13G · Filed Oct 15, 2026

Johnson & Johnson Innovation - JJDC, Inc. reported owning 5.3% of TRex Bio, Inc. (TRXB) (1,475,302 shares) in a Schedule 13G filed Oct 15, 2026.

A 13G is a passive stake: the holder does not plan to push for changes.

Stake

TRex Bio, Inc.

Stake

5.3% stake

More TRXB insider and Congress trades

Share this trade

From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.